healthcare stocks

Plus, a closer look at what it really takes to understand investing in biotechnology stocks.

Australia's biggest healthcare stock disappointed on guidance for FY25, sending its share price south.

KP Rx’s Hashan De Silva thinks so and is seeing enormous opportunities at attractive valuations.

It's been a wild ride for ResMed over the past couple of years and while there might be further volatility, things are back on track

...according to HB Biotechnology’s Charlie Williams.

The benchmark index closed the session on its high – usually a good sign there's more left in the tank, and gains were nicely broad-based.

There are two parts of the market we believe are setting up for strong returns in 2024: Small caps and Healthcare.

We weigh the latest blockbuster weight-loss drugs against pharmaceuticals (and others) that have gone before

In this episode, our guests name two growing healthcare stocks (and share their top tips for assessing the next generation of winners).

We think the current environment bodes well for healthcare which is considered a defensive sector, possessing characteristics that tend to outperform during economic...